News | tctmd.com

In-Depth

See all

Feature

Cardiology After COVID-19: Physicians Predict Lasting Change

By Yael L. Maxwell

Feature

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

By Michael O'Riordan

News

COVID-19: TCTMD’s Daily Dispatch for May 29

Avoiding hospitals out of COVID-19 fears, the quest for herd immunity, and more hydroxychloroquine controversy.

By Todd Neale

May 29, 2020

News

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

A group of scientists is asking for the numbers to be made public and externally validated. A Lancet study investigator responds.

By Michael O'Riordan

May 29, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Physicians latched quickly onto hopes that antimalarial drugs could help, but weren’t swayed by ACE inhibitor/ARB theories.

By Shelley Wood

May 29, 2020

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

News

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

By Yael L. Maxwell

May 29, 2020

News

Medtronic Recalls Parts of Its HeartWare VAD System

The company has received reports of pump outflow graft tears and breaks of the strain relief screw, with four patient deaths.

By Todd Neale

May 29, 2020

Medtronic Recalls Parts of Its HeartWare VAD System

News

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

The time has come to tackle the societal issues underlying cardiovascular health inequities, an editorialist asserts.

By L.A. McKeown

May 28, 2020

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Trial sponsors should incentivize recruiting sites to be more representative with their enrollment, says Erin Michos.

By Yael L. Maxwell

May 28, 2020

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

News • Interventional

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

Either fractional flow reserve or angiography can be used to guide nonculprit PCI, but a comparative study would be welcome.

By Todd Neale

May 27, 2020

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

Drug-Coated Balloons for CAD: Some International Consensus

With new US trials of coronary DCBs on the horizon, those already using them offer advice and a look to the future.

By L.A. McKeown

May 27, 2020

Drug-Coated Balloons for CAD: Some International Consensus

News • Interventional

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

There are caveats to this new registry analysis, but mortality and stroke rates were in line with TAVR outcomes in tricuspid AS.

By Michael O'Riordan

May 27, 2020

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Heart Sounds

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

Two large analyses reinforce the view that the antimalarial medications raise the risk of death and arrhythmia.

By Michael O'Riordan

May 26, 2020

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

See All News

Advertisement

In-Depth

Cardiology After COVID-19: Physicians Predict Lasting Change

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

COVID-19: TCTMD’s Daily Dispatch for May 29

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Medtronic Recalls Parts of Its HeartWare VAD System

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

Drug-Coated Balloons for CAD: Some International Consensus

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Top Stories in Cardiology: May 2020

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

Advertisement

@tctmd

Conference Coverage

HRS 2020

SCAI 2020

ACC 2020

Around the Web

Advertisement

Advertisement

In-Depth

Search News

Sign Up for Our Newsletter

Advertisement

@tctmd

Conference Coverage

Around the Web

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content